VERSANT HCV Genotype 2.0 Assay (LiPA)
Designed to identify and correctly detect multiple genotypes and subtypes
The VERSANT® HCV Genotype 2.0 Assay Line Probe Assay (LiPA) utilizes the trusted reverse-hybridization technology to detect genotypes 1-6 and 15 subtypes including 1a vs.1b and subtypes 6 (c-l) while also taking note of rare patterns that are contained in the updated interpretation chart. This assay is used with the Auto-LiPA 48* and AutoBlot 3000H* automated systems to provide highly accurate identification of HCV genotypes and subtypes for optimal patient therapy.
*Product availability varies from country to country and is subject to local regulatory requirements.
The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.